adenosine has been researched along with Cardiotoxicity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ansley, K; D'Agostino, RB; Douglas, E; Hundley, WG; Jordan, JH; Kotak, A; Melin, S; O'Connell, NS; Park, S; Romitti, PA; Sorscher, S; Thomas, A; Vasu, S | 1 |
| Agu, RU; Akhoundi, F; Purcell, C; Yeung, PK | 1 |
| Al Haleem, EN; El-Bakly, WM; El-Demerdash, E; Galal, A | 1 |
3 other study(ies) available for adenosine and Cardiotoxicity
| Article | Year |
|---|---|
Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor.
Topics: Adenosine; Adult; Age Factors; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Cardiotoxicity; Female; Humans; Magnetic Resonance Imaging; Microcirculation; Middle Aged; Ovary; Pilot Projects; Premenopause; Receptors, Estrogen; Stroke Volume; Triple Negative Breast Neoplasms; Ventricular Function, Left | 2021 |
Adenosine and Adenosine 5'-triphosphate Catabolism in Systemic Blood as a Potential Biomarker for Doxorubicin Cardiotoxicity in an Experimental Rat Model in vivo.
Topics: Adenosine; Animals; Biomarkers; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Male; Polyphosphates; Rats; Rats, Sprague-Dawley | 2018 |
Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Hemodynamics; Immunohistochemistry; Male; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Receptor, Adenosine A3 | 2016 |